Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma, Head And Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03799003
What this trial is testing

ASP1951 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Global Development, Inc. 119
Early research (Phase 1)Study completedNCT03538028
What this trial is testing

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Who this might be right for
Cervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more
Incyte Biosciences International Sàrl 22
Testing effectiveness (Phase 2)Study completedNCT02296684
What this trial is testing

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Who this might be right for
Cancer of Head and NeckHead and Neck CancerNeoplasms, Head and Neck+3 more
Washington University School of Medicine 67
Testing effectiveness (Phase 2)UnknownNCT06130007
What this trial is testing

A Prospective, Single-arm Phase II Clinical Trial of Tislelizumab Combined With Platinum Doublet Neoadjuvant Therapy to Improve Mandibular Preservation in Resectable Locally Advanced Oral Squamous Cell Carcinoma.

Who this might be right for
Oral Squamous Cell Carcinoma
Xuekui Liu 48
Early research (Phase 1)Study completedNCT03491709
What this trial is testing

A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC

Who this might be right for
Colorectal Cancer
Dragonboat Biopharmaceutical Company Limited 18
Testing effectiveness (Phase 2)Study completedNCT00833261
What this trial is testing

Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Texas Southwestern Medical Center 37
Testing effectiveness (Phase 2)Study completedNCT00939627
What this trial is testing

Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+34 more
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Looking for participantsNCT06006169
What this trial is testing

BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 186
Testing effectiveness (Phase 2)UnknownNCT02123381
What this trial is testing

Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Thoracic Middle-lower Segment Esophageal Squamous Cell Carcinoma
Sichuan Cancer Hospital and Research Institute 100
Early research (Phase 1)Study completedNCT02586207
What this trial is testing

Pembrolizumab in Combination With CRT for LA-SCCHN

Who this might be right for
Head and Neck CancerSquamous Cell CarcinomaOral Cavity Cancer+4 more
Sanford Health 59
Not applicableUnknownNCT06429865
What this trial is testing

Cytosponge in Surveillance After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Changhai Hospital 1,000
Not applicableStudy completedNCT06314711
What this trial is testing

Ex Vivo 3D-ultrasound for Oropharyngeal Cancer

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma
Rigshospitalet, Denmark 15
Large-scale testing (Phase 3)Study completedNCT01302834
What this trial is testing

Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer

Who this might be right for
Head and Neck CancerPrecancerous Condition
Radiation Therapy Oncology Group 987
Early research (Phase 1)Active Not RecruitingNCT06159621
What this trial is testing

CD40 Agonist and PD-1 Inhibitor in HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
University of Pennsylvania 27
Not applicableEnrolling By InvitationNCT07567716
What this trial is testing

Infiltration Pattern of Locally Advanced ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)InfiltrationTumour
Shanghai Chest Hospital 30
Testing effectiveness (Phase 2)Study completedNCT05271604
What this trial is testing

Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of Head and NeckRecurrent Squamous Cell Carcinoma of the Head and Neck+2 more
BioAtla, Inc. 42
Not applicableStudy completedNCT02379039
What this trial is testing

Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer

Who this might be right for
Squamous CarcinomaHead and Neck CancerAnal Cancer+3 more
Umeå University 118
Large-scale testing (Phase 3)Looking for participantsNCT06194734
What this trial is testing

KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Beijing Konruns Pharmaceutical Co., Ltd. 490
Early research (Phase 1)Ended earlyNCT00368329
What this trial is testing

Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal NeoplasmsCarcinoma, Squamous CellAdenocarcinoma+1 more
Stanford University 4
Testing effectiveness (Phase 2)Looking for participantsNCT05307939
What this trial is testing

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

Who this might be right for
HPVOropharynx CancerHPV-Related Carcinoma+2 more
Memorial Sloan Kettering Cancer Center 30
Next Page